Asia Pacific Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023

List of Tables

The Asia Pacific Arthritic Therapeutic Market would witness market growth of 6.0% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Arthritic Therapeutic Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $7,820.8 Million by 2030. The Japan market is registering a CAGR of 5.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.7% during (2023 - 2030).

Healthcare providers are more likely to adopt therapies supported by robust evidence of efficacy, safety, and long-term outcomes, while patients are more inclined to adhere to treatments that offer tangible benefits with minimal adverse effects. For instance, as per Invest India, India's healthcare industry is expanding at a rapid rate due to its expanding coverage, services, and rising expenditures by both public and private players.

Biologic agents, such as tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and Janus kinase (JAK) inhibitors, target specific inflammatory pathways implicated in autoimmune forms of arthritis, like psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis. These medications help suppress the immune system, reduce joint damage, and prevent structural deformities, thereby preserving joint function and improving long-term outcomes.

Telemedicine and digital health technologies enhance access to healthcare services for individuals residing in underserved or remote parts of India by overcoming geographical barriers. Digital health tools, encompassing wearable devices, mobile applications, and remote monitoring platforms, provide individuals with arthritis in India with enhanced capabilities to administer treatment remotely, trace disease activity, and monitor symptoms more efficiently. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.

Based on Application, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others. Based on Product Type, the market is segmented into Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

AbbVie, Inc.
Pfizer, Inc.
Amgen, Inc.
Novartis AG
F. Hoffmann-La Roche Ltd.
Viatris, Inc.
Bausch Health Companies, Inc.
Sanofi S.A.
Merck & Co., Inc.
Bristol-Myers Squibb Company

Asia Pacific Arthritic Therapeutic Market Report Segmentation

By Application

Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Others

By Product Type

Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Disease Modified Anti-rheumatoid Drugs (DMARDs)
Biologics
Others

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Asia Pacific Arthritic Therapeutic Market, by Application
- 1.4.2Asia Pacific Arthritic Therapeutic Market, by Product Type
- 1.4.3Asia Pacific Arthritic Therapeutic Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5.Asia Pacific Arthritic Therapeutic Market, by Application

5.1Asia Pacific Rheumatoid Arthritis Market, by Country
5.2Asia Pacific Psoriatic Arthritis Market, by Country
5.3Asia Pacific Osteoarthritis Market, by Country
5.4Asia Pacific Ankylosing Spondylitis Market, by Country
5.5Asia Pacific Others Market, by Country

Chapter 6.Asia Pacific Arthritic Therapeutic Market, by Product Type

6.1Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
6.2Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
6.3Asia Pacific Biologics Market, by Country
6.4Asia Pacific Others Market, by Country

Chapter 7.Asia Pacific Arthritic Therapeutic Market, by Country

7.1China Arthritic Therapeutic Market
- 7.1.1China Arthritic Therapeutic Market, by Application
- 7.1.2China Arthritic Therapeutic Market, by Product Type
7.2Japan Arthritic Therapeutic Market
- 7.2.1Japan Arthritic Therapeutic Market, by Application
- 7.2.2Japan Arthritic Therapeutic Market, by Product Type
7.3India Arthritic Therapeutic Market
- 7.3.1India Arthritic Therapeutic Market, by Application
- 7.3.2India Arthritic Therapeutic Market, by Product Type
7.4South Korea Arthritic Therapeutic Market
- 7.4.1South Korea Arthritic Therapeutic Market, by Application
- 7.4.2South Korea Arthritic Therapeutic Market, by Product Type
7.5Singapore Arthritic Therapeutic Market
- 7.5.1Singapore Arthritic Therapeutic Market, by Application
- 7.5.2Singapore Arthritic Therapeutic Market, by Product Type
7.6Malaysia Arthritic Therapeutic Market
- 7.6.1Malaysia Arthritic Therapeutic Market, by Application
- 7.6.2Malaysia Arthritic Therapeutic Market, by Product Type
7.7Rest of Asia Pacific Arthritic Therapeutic Market
- 7.7.1Rest of Asia Pacific Arthritic Therapeutic Market, by Application
- 7.7.2Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type

Chapter 8.Company Profiles

8.1AbbVie, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
8.2Pfizer, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Regional & Segmental Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Acquisition and Mergers:
- 8.2.6SWOT Analysis
8.3Amgen, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Acquisition and Mergers:
- 8.3.6SWOT Analysis
8.4Novartis AG
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expense
- 8.4.5Recent strategies and developments:
  - 8.4.5.1Trials and Approvals:
- 8.4.6SWOT Analysis
8.5F. Hoffmann-La Roche Ltd.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5SWOT Analysis
8.6Viatris, Inc.
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental Analysis
- 8.6.4Research & Development Expense
- 8.6.5Recent strategies and developments:
  - 8.6.5.1Trials and Approvals:
- 8.6.6SWOT Analysis
8.7Bausch Health Companies, Inc
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Sanofi S.A.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5Recent strategies and developments:
  - 8.8.5.1Partnerships, Collaborations, and Agreements:
- 8.8.6SWOT Analysis
8.9Merck & Co., Inc.
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5Recent strategies and developments:
  - 8.9.5.1Partnerships, Collaborations, and Agreements:
- 8.9.6SWOT Analysis
8.10.Bristol-Myers Squibb Company
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

LIST OF TABLES

TABLE 1Asia Pacific Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2Asia Pacific Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3Asia Pacific Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4Asia Pacific Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5Asia Pacific Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 6Asia Pacific Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 7Asia Pacific Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 8Asia Pacific Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 9Asia Pacific Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 10Asia Pacific Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 11Asia Pacific Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 12Asia Pacific Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 13Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 14Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 15Asia Pacific Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16Asia Pacific Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 18Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 19Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 20Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 21Asia Pacific Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 22Asia Pacific Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 23Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 24Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 25Asia Pacific Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 26Asia Pacific Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 27China Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28China Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29China Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30China Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31China Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 32China Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 33Japan Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 34Japan Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 35Japan Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 36Japan Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 37Japan Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 38Japan Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 39India Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 40India Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 41India Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 42India Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 43India Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 44India Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 45South Korea Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 46South Korea Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 47South Korea Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 48South Korea Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 49South Korea Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 50South Korea Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 51Singapore Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 52Singapore Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 53Singapore Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 54Singapore Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 55Singapore Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 56Singapore Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 57Malaysia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 58Malaysia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 59Malaysia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 60Malaysia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 61Malaysia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 62Malaysia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 63Rest of Asia Pacific Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 64Rest of Asia Pacific Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 65Rest of Asia Pacific Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 66Rest of Asia Pacific Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 67Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 68Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 69Key information - AbbVie, Inc.
TABLE 70Key Information - Pfizer, Inc.
TABLE 71Key Information - Amgen, Inc.
TABLE 72Key Information - Novartis AG
TABLE 73Key Information - F. Hoffmann-La Roche Ltd.
TABLE 74Key Information - Viatris, Inc.
TABLE 75key information - Bausch Health Companies, Inc.
TABLE 76Key Information - Sanofi S.A.
TABLE 77Key Information - Merck & Co., Inc.
TABLE 78Key Information - Bristol-Myers Squibb Company

Asia Pacific Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents